Another study has shown that the presence of at least one mutation in PIK3CA, BRAF, or KRAS genes predicts poor survival in a population-based colon cancer samples, however, the effect of PIK3CA mutations on survival, independently of clinical and other molecular predictors of outcome, was not described [31]. The gene discussed is BRAF; the disease is malignant colon neoplasm.